4.1 Article

The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Global Cancer Statistics, 2012

Lindsey A. Torre et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2015)

Article Oncology

Macrophages and Therapeutic Resistance in Cancer

Brian Ruffell et al.

CANCER CELL (2015)

Article Biochemistry & Molecular Biology

Long Noncoding RNA MALAT-1 Enhances Stem Cell-Like Phenotypes in Pancreatic Cancer Cells

Feng Jiao et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Review Oncology

Macrophage Regulation of Tumor Responses to Anticancer Therapies

Michele De Palma et al.

CANCER CELL (2013)

Review Multidisciplinary Sciences

Macrophage biology in development, homeostasis and disease

Thomas A. Wynn et al.

NATURE (2013)

Review Physiology

Immune infiltrates as predictive markers of survival in pancreatic cancer patients

Maria Pia Protti et al.

FRONTIERS IN PHYSIOLOGY (2013)

Review Immunology

Differential macrophage programming in the tumor microenvironment

Brian Ruffell et al.

TRENDS IN IMMUNOLOGY (2012)

Article Gastroenterology & Hepatology

Stromal biology and therapy in pancreatic cancer

Albrecht Neesse et al.

Article Surgery

Significance of M2-Polarized Tumor-Associated Macrophage in Pancreatic Cancer

Hiroshi Kurahara et al.

JOURNAL OF SURGICAL RESEARCH (2011)

Review Immunology

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

Subhra K. Biswas et al.

NATURE IMMUNOLOGY (2010)

Article Medicine, General & Internal

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Kathy Miller et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Review Biochemistry & Molecular Biology

Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis

J Condeelis et al.

Article Medicine, General & Internal

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

H Hurwitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)